• ISSN: 2349-6002
  • UGC Approved Journal No 47859
Author Login IJIRT Partner Network (IPN) Login

DEVELOPMENT OF DISSOLUTION TEST FOR DRONEDARONE HYDROCHLORIDE PHARMACEUTICAL FORMULATION

  • Unique Paper ID: 153089
  • Volume: 8
  • Issue: 5
  • PageNo: 431-435
  • Abstract:
  • Formulation quality control aspects are mainly deals with evaluation of dissolution and drug release profile of drugs from various dosage forms. In this study a RP-HPLC method was developed and validated for the dissolution study of Dronedarone Hydrochloride from tablet formulation. The validated method was applied for any other formulation due to its acceptability as per the ICH guidelines. The various validation parameters pass the acceptance criteria as per the ICH guidelines.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 8
  • Issue: 5
  • PageNo: 431-435

DEVELOPMENT OF DISSOLUTION TEST FOR DRONEDARONE HYDROCHLORIDE PHARMACEUTICAL FORMULATION

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry